medigraphic.com
ISSN 1405-8871 (Print)

2021, Number 1

<< Back Next >>

Aten Fam 2021; 28 (1)

Level of Knowledge about Therapeutic Uses of Cannabis in Physicians Attached to a Hospital in the State of Mexico

Velasco RK, Godínez TED

Language: Spanish
References: 18
Page: 49-53
PDF size: 153.83 Kb.


ABSTRACT

Objective: to identify the level of knowledge about the therapeutic uses of cannabis among medical personnel attached to a hospital in the State of Mexico. Methods: cross-sectional study. An eleven-question instrument was developed to identify the level of knowledge about therapeutic uses of Cannabis sativa and indica. The instrument classified the knowledge as sufficient, moderately sufficient and not sufficient; 31 general practitioners and specialists participated; descriptive statistics were made for the analysis of the obtained results. Results: 71% of the participants were men (22) and 29% women (9); 25% had graduate studies (8) and 74% had studied a specialty (23). In evaluating the level of knowledge about therapeutic uses of cannabis, it was found that 71% of the physicians had a moderately sufficient level of knowledge (22), 16.1%, sufficient knowledge (5) and 12.9%, not sufficient (4). Conclusions: most of the interviewed physicians had a moderately sufficient level of knowledge. It is important to carry out more studies on therapeutic use of cannabis, make a critical analysis of the evidence on this topic and, improve training and updating on possible therapeutic alternatives in general practitioners and specialists.


REFERENCES

  1. Avello A, Pastene E, Fernández P, Córdova P. Potencial uso terapéutico de cannabis. Rev. méd. Chile. 2017;145(3):360-367.

  2. Freeman T, Hindocha C, Green S, Blommfield M. Medicinal use of cannabis based products and cannabinoids. BMJ. 2019;365:l1141.

  3. Elliot J, DeJean D, Clifford T, Coyle D, Potter B, Skidmore B. Cannabis-based products for pediatric epilepsy: A sistematic review. Epilepsia. 2019;60(1):6-19.

  4. Costiniuk C, Saneei Z, Routy J, Margolese S, Mandarino E, Singer J. Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, torelabity and effect on inmune activation. BMJ Open. 2019;9(1):e024793.

  5. Gupta S, Fellows K, Weinstock-Guttman B, Hagemeier J, Zivadinov R, Ramanathan M. Marijuane use by patients with multiple sclerosis. Int J MS Care. 2019;21(2):57-62.

  6. Cohen K, Weizman A, Weinstein A. Positive and Negative effects and cannabis and cannabinoids on health. Clin Pharmacol Ther. 2019;105(5);1139- 1147.

  7. Diario Oficial de la Federación. Reglamento de la Ley General de Salud en Materia de Investigación para la Salud, Miércoles 2 de Abril 2014 (Primera Sección);89-95p.

  8. Kusturica M, Tomas A, Sabo A, Tomic Z, Horvat O. Medical cannabis: knoeledge and attitudes of prospective doctors in Serbia. Saudi Pharmaceutil Journal. 2019;27(3):320-325.

  9. Beltrán Caicedo RA. Uso terapéutico de la marihuana y sus consecuencias jurídicas en personas con enfermedades catastróficas [Tesis de licenciatura]. Ecuador.URAA;2016:64p.

  10. Vasconcelos S, Silva M, Moreira A, Correia A, Guerra A. Bioethical analysis to the therapeutic use of Cannabis: Integrative review. Nurs Ethics. 2019;26(1):96-104.

  11. Duvall S, Lindly O, Zuckerman K, Msall M, Weddle M. Ethical implications for providers regarding cannabis use in children with autism spectrum disorders. Pediatrics. 2019;143(2):e20180558.

  12. Philpot L, Ebbert J, Hurt R. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Family practice. 2019;20:17.

  13. Sideris A, Khan F, Boltunova A, Cuff G, Gharibo C, and Doan LV. Cannabis Cannabinoid Res. 2018;3(1):74-84.

  14. Chan M, Knoepke C, Cole M, McKinnon J, Matlock D. Colorado Medical Students’ Attitudes and Beliefs About Marijuana. J Gen Intern Med 2017;32(4):458-463.

  15. Brooks E, Gundersen D, Flynn E, Brooks-Russell A, Bull S. The clinical implicationsof legalizing marijuana: are physician and non-psysician providers prepared? Addict Behav. 2017;72:1-7.

  16. Sharon H, Goldway N, Goor-Aryeh I, Einsenberg E. Brill S. Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for the chronic pain. Journal of Pain Research. 2018;11:1411-1419

  17. Las disposiciones que regulan el uso de Cannabis con fines medicinales. [Internet]. [Citado 2020 May 25]. Disponible en: http://www.dof. gob.mx/nota_detalle.php?codigo=5339162&fec ha=02/04/2014#

  18. Medel Reyes MA. El significado que le otorgan los enfermos crónicos al uso de cannabis medicinal en su salud [Tesis de licenciatura]. Chile.UCC;2016:70p.




2020     |     www.medigraphic.com